- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05824572
The Effect of Clinic Visit Audio Recordings for Self-management in Older Adults (REPLAY)
August 5, 2026 updated by: Paul J. Barr, Dartmouth-Hitchcock Medical Center
The objective of this study is to conduct a multisite trial evaluating the impact of adding an audio recording of clinic visits (AUDIO) to usual care in older adults with multimorbidity, including diabetes, compared to After Visit Summary (AVS) alone (Usual Care; UC).
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Detailed Description
The objective of this study is to conduct a multisite trial evaluating the impact of adding an audio recording of clinic visits (AUDIO) to usual care in older adults with multimorbidity, including diabetes, compared to AVS alone (Usual Care; UC).
The specific aims are: Aim 1 Conduct a three-site trial in primary care where older patients with multimorbidity including diabetes (n=336) will be randomized to receive an audio recording as well as AVS (AUDIO) versus AVS alone (UC) for all scheduled clinic visits over 12 months; patients will be assessed at baseline, 1 week, 6 months and 12 months.
Applicants hypothesize (Main Effect) that: compared to those receiving UC, patients randomized to also receive audio recordings (AUDIO) of clinic visits will report a greater self-management ability (Primary Outcome), with improved quality of life, medication adherence, and satisfaction (Secondary Outcomes) at 12 months.
Study Type
Interventional
Enrollment (Estimated)
336
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New Hampshire
-
Manchester, New Hampshire, United States, 03104
- Dartmouth-Hitchcook Manchester
-
-
Tennessee
-
Nashville, Tennessee, United States, 37232
- Vanderbit University Medical Center
-
-
Texas
-
Galveston, Texas, United States, 77555
- University of Texas Medical Branch
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Older Adult
Accepts Healthy Volunteers
No
Description
Patients participants:
Inclusion Criteria:
- Patients who are ≥ 65 years;
- Patients with multimorbidity (i.e. patient has diabetes and one or more chronic conditions including: arthritis, asthma, atrial fibrillation, cancer, chronic obstructive pulmonary disease, heart disease, depression, heart failure, hypertension, osteoporosis, kidney disease and stroke);
- Have had two or more clinic visits in the previous 12 months;
- Plan on receiving ongoing care at the clinic for the subsequent 12 months;
- Do not have any vision or hearing problems that cannot be corrected;
- Have not recorded a clinic visit for personal use i the past 6 months.
Exclusion Criteria:
- Without capacity to consent to the project;
- With schizophrenia and other psychotic disorders, substance-use disorders, uncorrectable hearing or visual impairment or a six item screener (SIS) cognitive function score ≤ 4;
- Living in skilled nursing homes or hospice;
- Patients who have audio- recorded a clinic visit for their personal use in the previous six months;
- Patients who do not speak English or Spanish;
- Patients who lack internet access;
- Patients who (a) do not have access to a personal email, (b) do not have an email address shared with a family member or patient-identified caregiver, and (c) are not interested in creating an email account between the time they are first contacted by the study team to the time that the study team requires an email address to initiate the online recording software registration.
Clinician participants:
Inclusion criteria:
- Licensed clinician (MD including clinician residents at Dartmouth Health locations, DO, APRN, NP, PA)
- Are based at the study clinic;
- Who treat adult patients.
Exclusion criteria:
- Are trainees, e.g., fellows, medical students or residents, with the exception of clinician residents at Dartmouth Health;
- Commonly audio or video record clinic visits for patient's personal use.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Audio
Researchers will audio record both in-person and telehealth visits of participants in the intervention group.
|
The intervention is audio-recordings of primary care clinic visits that are shared with participating patients.
All scheduled visits with study clinicians will be recorded and shared with patients randomized to the intervention group (AUDIO) for 12 months.
|
|
Placebo Comparator: Usual care
Participants will receive Usual Care
|
The Usual Care arm participants will receive After Visit Summaries (AVS) per the standard delivery at each institution
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient Activation Measure-Short Form
Time Frame: Patient activation at 12-months from enrollment
|
The Patient Activation Measure-Short Form is a 13-item patient reported measure.
Scores range from 0 (low activation) to 100 (high activation).
|
Patient activation at 12-months from enrollment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Adherence to Refills and Medications-D (ARMS-D)
Time Frame: Adherence at 12-months from enrollment
|
Eleven-item measure of medication adherence in diabetes.
Two domains: i) Medication taking; and ii) medication refill.
|
Adherence at 12-months from enrollment
|
|
Global PROMIS 10
Time Frame: Global PROMIS 10 at 12 month from enrollment
|
Global PROMIS (Patient-Reported Outcome Measurement Information System) is a 10-item patient reported measure with two domains: mental and physical health.
Domain scores range from 4 to 20, with higher scores representing better health.
|
Global PROMIS 10 at 12 month from enrollment
|
|
Patient Satisfaction Questionnaire-18
Time Frame: Patient satisfaction at 12-months from enrollment
|
Patient Satisfaction Questionnaire-18 (PSQ-18) is a patient reported measure of satisfaction.
It assesses seven sub-scales of satisfaction with care with scores ranging from 1 - 5 for each.
We will use the two-item domain assessing general satisfaction.
|
Patient satisfaction at 12-months from enrollment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Paul J Barr, PhD, Dartmouth College
- Principal Investigator: Kerri L Cavanaugh, MD, Vanderbilit University Medical Center
- Principal Investigator: Meredith C Masel, PhD, University Texas Medical Branch
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 1, 2023
Primary Completion (Estimated)
June 30, 2027
Study Completion (Estimated)
December 31, 2027
Study Registration Dates
First Submitted
April 7, 2023
First Submitted That Met QC Criteria
April 19, 2023
First Posted (Actual)
April 21, 2023
Study Record Updates
Last Update Posted (Actual)
August 7, 2026
Last Update Submitted That Met QC Criteria
August 5, 2026
Last Verified
August 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY02001844
- 1R01AG074959-01A1 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Upon publication of results in peer-reviewed journals, access to the de-identified data for research purposes will be considered if a request is made by a qualified individual (i.e., a researcher from a research institute), IRB secured, and mutually agreed upon by the PIs.
Any potential users of the data will sign an agreement that no attempt to reveal personal or private information may be made.
The investigators will follow the Safe Harbour Methods outlined in the guidance regarding methods for de-identification of protected health information in accordance with the HIPAA Privacy Rule.
IPD Sharing Time Frame
At the completion of data analysis
IPD Sharing Access Criteria
Contact PI to request data
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.